Auction: packaging equipment of vaccines and injectables from Pfizer

Published: 24-Sep-2020
Manufacturing

The auction of products from Pfizer Havant, UK, will take place 11-12 November, 2020


Federal Equipment's upcoming auction in November features state-of-the-art packaging equipment of vaccines and injectable products. Equipment includes downstream packaging equipment for pre-filled syringe, pen, or vial.

Sale Information:

  • Location: Havant, United Kindom
  • Sale Held In Conjunction With: Heritage Global Partners
  • Bid Online: November 11-12, 2020
  • Preview: By Appointment Only
  • Sale Conducted In: $USD / 18% Buyers Premium
  • Contact: Adam Covitt: 216.536.0312 | adam@fedequip.com

Key Packaging Line Assets Including:

  • Uhlman Case Packer Model 4046E
  • Uhlman Palletizer Model P5020
  • Farmo Res Re-Nester RN200
  • Soco Case Sealer T10
  • Garvens Case Checkweigher S3
  • Corima De-Nester MPT 100L
  • Corima Syringe Labeler AEC 212
  • Corima Backstop Applicator SMB12
  • Farcon Thermoformer FC420
  • IMA Case Packer CP28 BA
  • Uhlman Carton Bander 3040E
  • Kora and Packmat Leaflet Inserter
  • and much more!
  • Companies:
  • Federal Equipment Company
  • Pfizer
See more

You may also like

Manufacturing

Samsung Biologics and Pfizer's collaboration for manufacturing of biosimilars

Read more
Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product biosimilars portfolio

Trending Articles

  1. Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its large-scale spray drying unit (GEA PSD-4) at its Boston (MA, US) facility
  2. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  3. Scinai Immunotherapeutics establishes Delaware-based US CDMO subsidiary The biopharmaceutical company now operates contract development and manufacturing services in both Jerusalem and Delaware
  4. Implementing advanced manufacturing technologies for novel therapies Michele Ghinizzini, Senior Vice President, Global Head of Engineering and Maintenance at Sanofi, explores the elements that enable the realistic implementation of advanced technologies in drug development and manufacturing
  5. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within rare disease indications

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Samsung Biologics and Pfizer's collaboration for manufacturing of biosimilars

Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product biosimilars portfolio
Manufacturing

Tickets now on sale for 2023 Manufacturing Chemist Live

Super early bird tickets are now on sale for the annual conference due to take place in Birmingham on 24 – 25 May 2023
Manufacturing

Manufacturing Chemist LIVE 2023: Become an official sponsor

Taking place on 24 – 25 May 2023 at the National Conference Centre in Birmingham, the annual Manufacturing Chemist LIVE event is offering a unique opportunity to get your name recognised across the pharmaceutical sector as well as those using cleanrooms
Manufacturing

CMC Pharmaceuticals makes mutually beneficial partnership

CMC has partnered with Federal Equipment Company that grants CMC Pharma access to a wider range of equipment, expanding prototype preparation and manufacturing process development capabilities
Manufacturing

AGC to support Pfizer-BioNTech Omicron vaccine

Plasmid DNA from AGC is already supplied as a starting material for the companies' COVID-19 vaccine
Manufacturing

Eurofarma to manufacture Pfizer-BioNTech doses for Latin America

Annual production is planned to exceed 100 million COVID-19 vaccine doses annually and all of these will exclusively be distributed within Latin America
Manufacturing

Biovac to manufacture Pfizer-BioNTech vaccine for African Union

Pfizer and BioNTech expect the Cape Town facility to be incorporated into the vaccine supply chain by the end of 2021
Subscribe now